You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR PARATHYROID HORMONE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for parathyroid hormone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000400 ↗ Alendronate and/or Parathyroid Hormone for Osteoporosis Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Phase 2 1999-08-01 This study looks at the effects of two medications, alendronate and parathyroid hormone, on bone mass and on bone formation and bone breakdown in women with osteoporosis. We will randomly select postmenopausal women who have osteoporosis to receive laboratory-produced human parathyroid hormone (hPTH), or alendronate, or both for 2.5 years. Study participants will return to the study center periodically to have their bone mass measured and to give blood and urine samples for tests of bone formation and breakdown and for other laboratory tests. Those who complete the study are eligible for one or two 12 month extension studies.
NCT00000400 ↗ Alendronate and/or Parathyroid Hormone for Osteoporosis Completed Massachusetts General Hospital Phase 2 1999-08-01 This study looks at the effects of two medications, alendronate and parathyroid hormone, on bone mass and on bone formation and bone breakdown in women with osteoporosis. We will randomly select postmenopausal women who have osteoporosis to receive laboratory-produced human parathyroid hormone (hPTH), or alendronate, or both for 2.5 years. Study participants will return to the study center periodically to have their bone mass measured and to give blood and urine samples for tests of bone formation and breakdown and for other laboratory tests. Those who complete the study are eligible for one or two 12 month extension studies.
NCT00000427 ↗ Effects of Parathyroid Hormone in Men With Osteoporosis Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Phase 3 1999-09-01 Alendronate is a drug that blocks or reduces bone loss, while parathyroid hormone (PTH) stimulates the formation of new bone. The purpose of this study is to compare the bone-building effects of PTH alone, alendronate alone, and both PTH and alendronate in men with osteoporosis over a two-and-a-half year period.
NCT00000427 ↗ Effects of Parathyroid Hormone in Men With Osteoporosis Completed Massachusetts General Hospital Phase 3 1999-09-01 Alendronate is a drug that blocks or reduces bone loss, while parathyroid hormone (PTH) stimulates the formation of new bone. The purpose of this study is to compare the bone-building effects of PTH alone, alendronate alone, and both PTH and alendronate in men with osteoporosis over a two-and-a-half year period.
NCT00000543 ↗ Oral Calcium in Pregnant Women With Hypertension Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1993-08-01 To determine of providing calcium supplementation to women with pre-existing hypertension reduces the level of blood pressure, requirement for antihypertensive drugs, and incidence of pre-eclampsia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for parathyroid hormone

Condition Name

Condition Name for parathyroid hormone
Intervention Trials
Osteoporosis 40
Vitamin D Deficiency 34
Secondary Hyperparathyroidism 29
Chronic Kidney Disease 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for parathyroid hormone
Intervention Trials
Hyperparathyroidism 66
Kidney Diseases 57
Renal Insufficiency, Chronic 56
Hyperparathyroidism, Secondary 48
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for parathyroid hormone

Trials by Country

Trials by Country for parathyroid hormone
Location Trials
United States 556
Canada 40
China 27
Spain 24
Mexico 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for parathyroid hormone
Location Trials
New York 48
California 32
Texas 30
Pennsylvania 29
Illinois 29
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for parathyroid hormone

Clinical Trial Phase

Clinical Trial Phase for parathyroid hormone
Clinical Trial Phase Trials
Phase 4 70
Phase 3 60
Phase 2/Phase 3 6
[disabled in preview] 62
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for parathyroid hormone
Clinical Trial Phase Trials
Completed 183
Recruiting 26
Terminated 26
[disabled in preview] 36
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for parathyroid hormone

Sponsor Name

Sponsor Name for parathyroid hormone
Sponsor Trials
Amgen 17
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 17
Shire 13
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for parathyroid hormone
Sponsor Trials
Other 313
Industry 112
NIH 58
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.